Cargando…

Nonperfusion Area and Other Vascular Metrics by Wider Field Swept-Source OCT Angiography as Biomarkers of Diabetic Retinopathy Severity

PURPOSE: To study the wider field (WF) swept-source OCT angiography (SS-OCTA) metrics, especially the nonperfusion area (NPA), in the diagnosing and staging of diabetic retinopathy (DR). DESIGN: Cross-sectional observational study (November 2018 to September 2020). PARTICIPANTS: A total of 473 eyes...

Descripción completa

Detalles Bibliográficos
Autores principales: Garg, Itika, Uwakwe, Chibuike, Le, Rongrong, Lu, Edward S., Cui, Ying, Wai, Karen M., Katz, Raviv, Zhu, Ying, Moon, Jade Y., Li, Chloe Y., Laíns, Inês, Eliott, Dean, Elze, Tobias, Kim, Leo A., Wu, David M., Miller, Joan W., Husain, Deeba, Vavvas, Demetrios G., Miller, John B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137369/
https://www.ncbi.nlm.nih.gov/pubmed/35647573
http://dx.doi.org/10.1016/j.xops.2022.100144
_version_ 1784714363444133888
author Garg, Itika
Uwakwe, Chibuike
Le, Rongrong
Lu, Edward S.
Cui, Ying
Wai, Karen M.
Katz, Raviv
Zhu, Ying
Moon, Jade Y.
Li, Chloe Y.
Laíns, Inês
Eliott, Dean
Elze, Tobias
Kim, Leo A.
Wu, David M.
Miller, Joan W.
Husain, Deeba
Vavvas, Demetrios G.
Miller, John B.
author_facet Garg, Itika
Uwakwe, Chibuike
Le, Rongrong
Lu, Edward S.
Cui, Ying
Wai, Karen M.
Katz, Raviv
Zhu, Ying
Moon, Jade Y.
Li, Chloe Y.
Laíns, Inês
Eliott, Dean
Elze, Tobias
Kim, Leo A.
Wu, David M.
Miller, Joan W.
Husain, Deeba
Vavvas, Demetrios G.
Miller, John B.
author_sort Garg, Itika
collection PubMed
description PURPOSE: To study the wider field (WF) swept-source OCT angiography (SS-OCTA) metrics, especially the nonperfusion area (NPA), in the diagnosing and staging of diabetic retinopathy (DR). DESIGN: Cross-sectional observational study (November 2018 to September 2020). PARTICIPANTS: A total of 473 eyes of 286 patients (69 eyes of 49 control patients and 404 eyes of 237 diabetic patients). METHODS: We imaged using 6 × 6 mm and 12 × 12 mm angiograms on WF SS-OCTA. Images were analyzed using the ARI Network and FIJI ImageJ. Mixed effects multiple regression models and receiver operating characteristic (ROC) analysis were used for statistical analyses. MAIN OUTCOME MEASURES: Quantitative metrics such as vessel density (VD); vessel skeletonized density (VSD); foveal avascular zone (FAZ) area, circularity, and perimeter; and NPA in DR and their relative performance for its diagnosis and grading. RESULTS: Among patients with diabetes (median age, 59 years), 51 eyes had no DR, 185 eyes (88 mild, 97 moderate-severe) had nonproliferative DR (NPDR), and 168 eyes had proliferative DR (PDR). Trend analysis revealed a progressive decline in superficial capillary plexus (SCP) VD and VSD, and increased NPA with increasing DR severity. Additionally, there was a significant reduction in deep capillary plexus (DCP) VD and VSD in early DR (mild NPDR), but the progressive reduction in advanced DR stages was not significant. The NPA was the best parameter to diagnose DR (area under the curve [AUC], 0.96), whereas all parameters combined on both angiograms efficiently diagnosed (AUC, 0.97) and differentiated between DR stages (AUC range, 0.83–0.97). The presence of diabetic macular edema was associated with reduced SCP and DCP VD and VSD within mild NPDR eyes, whereas increased VD and VSD in SCP were observed in the moderate-severe NPDR group. CONCLUSIONS: Our work highlights the importance of NPA, which can be measured more readily and easily with WF SS-OCTA compared with fluorescein angiography. It is quick and noninvasive, and thus can be an important adjunct for DR diagnosis and management. In our study, a combination of all OCTA metrics on both 6 × 6 mm and 12 × 12 mm angiograms had the best diagnostic accuracy for DR and its severity. Further longitudinal studies are needed to assess NPA as a biomarker for progression or regression of DR severity.
format Online
Article
Text
id pubmed-9137369
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-91373692022-06-01 Nonperfusion Area and Other Vascular Metrics by Wider Field Swept-Source OCT Angiography as Biomarkers of Diabetic Retinopathy Severity Garg, Itika Uwakwe, Chibuike Le, Rongrong Lu, Edward S. Cui, Ying Wai, Karen M. Katz, Raviv Zhu, Ying Moon, Jade Y. Li, Chloe Y. Laíns, Inês Eliott, Dean Elze, Tobias Kim, Leo A. Wu, David M. Miller, Joan W. Husain, Deeba Vavvas, Demetrios G. Miller, John B. Ophthalmol Sci Original Article PURPOSE: To study the wider field (WF) swept-source OCT angiography (SS-OCTA) metrics, especially the nonperfusion area (NPA), in the diagnosing and staging of diabetic retinopathy (DR). DESIGN: Cross-sectional observational study (November 2018 to September 2020). PARTICIPANTS: A total of 473 eyes of 286 patients (69 eyes of 49 control patients and 404 eyes of 237 diabetic patients). METHODS: We imaged using 6 × 6 mm and 12 × 12 mm angiograms on WF SS-OCTA. Images were analyzed using the ARI Network and FIJI ImageJ. Mixed effects multiple regression models and receiver operating characteristic (ROC) analysis were used for statistical analyses. MAIN OUTCOME MEASURES: Quantitative metrics such as vessel density (VD); vessel skeletonized density (VSD); foveal avascular zone (FAZ) area, circularity, and perimeter; and NPA in DR and their relative performance for its diagnosis and grading. RESULTS: Among patients with diabetes (median age, 59 years), 51 eyes had no DR, 185 eyes (88 mild, 97 moderate-severe) had nonproliferative DR (NPDR), and 168 eyes had proliferative DR (PDR). Trend analysis revealed a progressive decline in superficial capillary plexus (SCP) VD and VSD, and increased NPA with increasing DR severity. Additionally, there was a significant reduction in deep capillary plexus (DCP) VD and VSD in early DR (mild NPDR), but the progressive reduction in advanced DR stages was not significant. The NPA was the best parameter to diagnose DR (area under the curve [AUC], 0.96), whereas all parameters combined on both angiograms efficiently diagnosed (AUC, 0.97) and differentiated between DR stages (AUC range, 0.83–0.97). The presence of diabetic macular edema was associated with reduced SCP and DCP VD and VSD within mild NPDR eyes, whereas increased VD and VSD in SCP were observed in the moderate-severe NPDR group. CONCLUSIONS: Our work highlights the importance of NPA, which can be measured more readily and easily with WF SS-OCTA compared with fluorescein angiography. It is quick and noninvasive, and thus can be an important adjunct for DR diagnosis and management. In our study, a combination of all OCTA metrics on both 6 × 6 mm and 12 × 12 mm angiograms had the best diagnostic accuracy for DR and its severity. Further longitudinal studies are needed to assess NPA as a biomarker for progression or regression of DR severity. Elsevier 2022-03-18 /pmc/articles/PMC9137369/ /pubmed/35647573 http://dx.doi.org/10.1016/j.xops.2022.100144 Text en © 2022 by the American Academy of Ophthalmology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Garg, Itika
Uwakwe, Chibuike
Le, Rongrong
Lu, Edward S.
Cui, Ying
Wai, Karen M.
Katz, Raviv
Zhu, Ying
Moon, Jade Y.
Li, Chloe Y.
Laíns, Inês
Eliott, Dean
Elze, Tobias
Kim, Leo A.
Wu, David M.
Miller, Joan W.
Husain, Deeba
Vavvas, Demetrios G.
Miller, John B.
Nonperfusion Area and Other Vascular Metrics by Wider Field Swept-Source OCT Angiography as Biomarkers of Diabetic Retinopathy Severity
title Nonperfusion Area and Other Vascular Metrics by Wider Field Swept-Source OCT Angiography as Biomarkers of Diabetic Retinopathy Severity
title_full Nonperfusion Area and Other Vascular Metrics by Wider Field Swept-Source OCT Angiography as Biomarkers of Diabetic Retinopathy Severity
title_fullStr Nonperfusion Area and Other Vascular Metrics by Wider Field Swept-Source OCT Angiography as Biomarkers of Diabetic Retinopathy Severity
title_full_unstemmed Nonperfusion Area and Other Vascular Metrics by Wider Field Swept-Source OCT Angiography as Biomarkers of Diabetic Retinopathy Severity
title_short Nonperfusion Area and Other Vascular Metrics by Wider Field Swept-Source OCT Angiography as Biomarkers of Diabetic Retinopathy Severity
title_sort nonperfusion area and other vascular metrics by wider field swept-source oct angiography as biomarkers of diabetic retinopathy severity
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137369/
https://www.ncbi.nlm.nih.gov/pubmed/35647573
http://dx.doi.org/10.1016/j.xops.2022.100144
work_keys_str_mv AT gargitika nonperfusionareaandothervascularmetricsbywiderfieldsweptsourceoctangiographyasbiomarkersofdiabeticretinopathyseverity
AT uwakwechibuike nonperfusionareaandothervascularmetricsbywiderfieldsweptsourceoctangiographyasbiomarkersofdiabeticretinopathyseverity
AT lerongrong nonperfusionareaandothervascularmetricsbywiderfieldsweptsourceoctangiographyasbiomarkersofdiabeticretinopathyseverity
AT luedwards nonperfusionareaandothervascularmetricsbywiderfieldsweptsourceoctangiographyasbiomarkersofdiabeticretinopathyseverity
AT cuiying nonperfusionareaandothervascularmetricsbywiderfieldsweptsourceoctangiographyasbiomarkersofdiabeticretinopathyseverity
AT waikarenm nonperfusionareaandothervascularmetricsbywiderfieldsweptsourceoctangiographyasbiomarkersofdiabeticretinopathyseverity
AT katzraviv nonperfusionareaandothervascularmetricsbywiderfieldsweptsourceoctangiographyasbiomarkersofdiabeticretinopathyseverity
AT zhuying nonperfusionareaandothervascularmetricsbywiderfieldsweptsourceoctangiographyasbiomarkersofdiabeticretinopathyseverity
AT moonjadey nonperfusionareaandothervascularmetricsbywiderfieldsweptsourceoctangiographyasbiomarkersofdiabeticretinopathyseverity
AT lichloey nonperfusionareaandothervascularmetricsbywiderfieldsweptsourceoctangiographyasbiomarkersofdiabeticretinopathyseverity
AT lainsines nonperfusionareaandothervascularmetricsbywiderfieldsweptsourceoctangiographyasbiomarkersofdiabeticretinopathyseverity
AT eliottdean nonperfusionareaandothervascularmetricsbywiderfieldsweptsourceoctangiographyasbiomarkersofdiabeticretinopathyseverity
AT elzetobias nonperfusionareaandothervascularmetricsbywiderfieldsweptsourceoctangiographyasbiomarkersofdiabeticretinopathyseverity
AT kimleoa nonperfusionareaandothervascularmetricsbywiderfieldsweptsourceoctangiographyasbiomarkersofdiabeticretinopathyseverity
AT wudavidm nonperfusionareaandothervascularmetricsbywiderfieldsweptsourceoctangiographyasbiomarkersofdiabeticretinopathyseverity
AT millerjoanw nonperfusionareaandothervascularmetricsbywiderfieldsweptsourceoctangiographyasbiomarkersofdiabeticretinopathyseverity
AT husaindeeba nonperfusionareaandothervascularmetricsbywiderfieldsweptsourceoctangiographyasbiomarkersofdiabeticretinopathyseverity
AT vavvasdemetriosg nonperfusionareaandothervascularmetricsbywiderfieldsweptsourceoctangiographyasbiomarkersofdiabeticretinopathyseverity
AT millerjohnb nonperfusionareaandothervascularmetricsbywiderfieldsweptsourceoctangiographyasbiomarkersofdiabeticretinopathyseverity